HomeCompareITOCY vs PFE

ITOCY vs PFE: Dividend Comparison 2026

ITOCY yields 2.11% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ITOCY wins by $80.69M in total portfolio value
10 years
ITOCY
ITOCY
● Live price
2.11%
Share price
$12.49
Annual div
$0.26
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.74M
Annual income
$73,994,158.64
Full ITOCY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ITOCY vs PFE

📍 ITOCY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodITOCYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ITOCY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ITOCY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ITOCY
Annual income on $10K today (after 15% tax)
$179.23/yr
After 10yr DRIP, annual income (after tax)
$62,895,034.84/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, ITOCY beats the other by $62,872,714.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ITOCY + PFE for your $10,000?

ITOCY: 50%PFE: 50%
100% PFE50/50100% ITOCY
Portfolio after 10yr
$40.39M
Annual income
$37,010,208.68/yr
Blended yield
91.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ITOCY
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
2.5
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ITOCY buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricITOCYPFE
Forward yield2.11%6.13%
Annual dividend / share$0.26$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$80.74M$49.6K
Annual income after 10y$73,994,158.64$26,258.71
Total dividends collected$80.20M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: ITOCY vs PFE ($10,000, DRIP)

YearITOCY PortfolioITOCY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,122$421.73$9,153$693.39+$2.0KITOCY
2$12,777$876.70$8,593$849.25+$4.2KITOCY
3$15,554$1,882.58$8,336$1,066.78+$7.2KITOCY
4$20,926$4,283.63$8,437$1,384.80+$12.5KITOCY
5$33,164$10,772.38$9,013$1,875.40+$24.2KITOCY
6$67,395$31,909.94$10,306$2,680.72+$57.1KITOCY
7$193,323$121,210.02$12,820$4,101.38+$180.5KITOCY
8$856,745$649,890.28$17,673$6,826.70+$839.1KITOCY
9$6,300,102$5,383,384.81$27,543$12,591.86+$6.27MITOCY
10$80,735,268$73,994,158.64$49,560$26,258.71+$80.69MITOCY

ITOCY vs PFE: Complete Analysis 2026

ITOCYStock

ITOCHU Corporation trades and imports/exports various products worldwide. The Textile segment produces and sells raw materials, threads, and textiles; and garments, home furnishings, and industrial materials. Its Machinery segment engages in the plants, bridges, railways, and other infrastructure; power generation, transmission, transformation, and electricity sale; water, environment and waste-related; trading of ships, aircraft, automobiles, construction and industrial machinery, machine tools, environmental equipment, electronic devices, and related equipment; renewable and alternative energy; and waste recycling businesses. The Metals & Minerals segment develops metal and mineral resource; processes steel products; trades iron ore, coal, pig iron and ferrous raw materials, non-ferrous and light metals, steel products, nuclear fuels, and greenhouse gas emissions; and recycles and waste treatment activities. Its Energy & Chemicals segment trades in crude oil, petroleum product, LPG, LNG, natural gas, hydrogen, organic and inorganic chemicals, functional food, synthetic resins, semiconductors, packaging materials, fine chemicals, pharmaceuticals, and electronic materials, as well as engages in the solar and biomass power generation, electricity trading, and the energy storage cell businesses. The Food segment produces, distributes, and retails food products. Its General Products & Realty segment produces and sells paper, pulp, natural rubber, tire, and building products and materials; develops, sells, leases, and operates real estate properties, such as housing, logistics facilities, and other projects; and offers logistics services. The ICT & Financial Business segment offers IT, Internet related and venture capital; distributes mobile telephone devices; and BPO, medical and healthcare, space/ satellite, IP content, digital marketing, and financial, reinsurance, and insurance brokerage services. The company was founded in 1858 and is headquartered in Tokyo, Japan.

Full ITOCY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ITOCY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ITOCY vs SCHDITOCY vs JEPIITOCY vs OITOCY vs KOITOCY vs MAINITOCY vs JNJITOCY vs MRKITOCY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.